International Products

Product Overview

TransWorld Heart CorporationTM has developed a patented and patent-pending medical device based system to replace the current method of routine post-transplant heart biopsies. This system, the use of which is supported by leading cardiologists, will result in the elimination of frequent, sometimes painful, and costly biopsies while providing improved care and a higher quality of life. Based on patent- pending algorithms, our diagnostic approach to monitoring post-transplant heart health consists of an implanted monitoring device and proprietary software that will provide cardiologists with real-time heart health data. We believe that a significant medical and market opportunity exists for our device-based therapy which overcomes the problems associated with heart biopsies while providing cardiologists with a far more detailed, daily picture of heart health.

Click here for SoulMateTM information